IL92009A - נוגדן חד-שבטי או אזור אידיוטופי אנטי-אידיוטיפי של בני אדם ותכשירי רוקחות המכילים אותו - Google Patents

נוגדן חד-שבטי או אזור אידיוטופי אנטי-אידיוטיפי של בני אדם ותכשירי רוקחות המכילים אותו

Info

Publication number
IL92009A
IL92009A IL9200989A IL9200989A IL92009A IL 92009 A IL92009 A IL 92009A IL 9200989 A IL9200989 A IL 9200989A IL 9200989 A IL9200989 A IL 9200989A IL 92009 A IL92009 A IL 92009A
Authority
IL
Israel
Prior art keywords
antibody
antigen
human
idiotypic
monoclonal antibody
Prior art date
Application number
IL9200989A
Other languages
English (en)
Other versions
IL92009A0 (en
Original Assignee
Cancer Res Campaign Tech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cancer Res Campaign Tech filed Critical Cancer Res Campaign Tech
Publication of IL92009A0 publication Critical patent/IL92009A0/xx
Publication of IL92009A publication Critical patent/IL92009A/he

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3046—Stomach, Intestines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4241—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
    • C07K16/4258—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig
    • C07K16/4266—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig against anti-tumor receptor Ig
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y10S530/809—Fused cells, e.g. hybridoma

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL9200989A 1988-10-17 1989-10-16 נוגדן חד-שבטי או אזור אידיוטופי אנטי-אידיוטיפי של בני אדם ותכשירי רוקחות המכילים אותו IL92009A (he)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US25891188A 1988-10-17 1988-10-17

Publications (2)

Publication Number Publication Date
IL92009A0 IL92009A0 (en) 1990-07-12
IL92009A true IL92009A (he) 1994-12-29

Family

ID=22982661

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9200989A IL92009A (he) 1988-10-17 1989-10-16 נוגדן חד-שבטי או אזור אידיוטופי אנטי-אידיוטיפי של בני אדם ותכשירי רוקחות המכילים אותו

Country Status (9)

Country Link
US (1) US6042827A (he)
EP (1) EP0440689B1 (he)
JP (1) JP3095169B2 (he)
AT (1) ATE130764T1 (he)
AU (1) AU634181B2 (he)
DE (1) DE68924983T2 (he)
IL (1) IL92009A (he)
NZ (1) NZ231037A (he)
WO (1) WO1990004415A1 (he)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE189122T1 (de) * 1993-05-27 2000-02-15 Uwe Dr Med Wagner Monoklonale anti-idiotypische anti - ca125 antikörper und sie enthaltende pharmazeutische zusammensetzung
WO1997032021A1 (en) * 1996-02-28 1997-09-04 Cancer Research Campaign Technology Limited Therapeutic agents based on monoclonal anti-idiotypic antibody 105ad7
ATE296839T1 (de) 1999-03-01 2005-06-15 Genentech Inc Antikörper zur krebsbehandlung und -diagnose
DE10352977A1 (de) * 2003-11-13 2005-06-09 Müller-Hermelink, Hans Konrad, Prof. Dr. Muriner anti Idiotyp-Antikörpers oder anti Idiotyp-Antikörper aus der Ratte des humanen monoklonalen SC-1 Antikörpers
US7976852B2 (en) 2005-04-26 2011-07-12 Eisai R&D Management Co., Ltd. Compositions and methods for cancer immunotherapy
EP1801594A1 (en) * 2005-12-23 2007-06-27 Koninklijke Philips Electronics N.V. Sensing device and method for determination of the amount of target molecule in an analyte
CN102764435B (zh) * 2012-08-03 2014-04-16 中国农业科学院兰州兽医研究所 一种猪用亚洲i型口蹄疫病毒灭活疫苗佐剂及制备方法
US20220315670A1 (en) * 2019-09-10 2022-10-06 The Research Foundation For The State University Of New York Compositions and methods for improving tumor penetration of tumor specific antibodies

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4708862A (en) * 1983-02-22 1987-11-24 Xoma Corporation Radioimmuno detection of human cancers using anti-tumor monoclonal antibody
US4699880A (en) * 1984-09-25 1987-10-13 Immunomedics, Inc. Method of producing monoclonal anti-idiotype antibody
US4918164A (en) * 1987-09-10 1990-04-17 Oncogen Tumor immunotherapy using anti-idiotypic antibodies
US4699830A (en) * 1986-06-30 1987-10-13 Baxter Travenol Laboratories, Inc. Laminated sheet material for packaging electronic components

Also Published As

Publication number Publication date
EP0440689A1 (en) 1991-08-14
EP0440689B1 (en) 1995-11-29
NZ231037A (en) 1992-03-26
JPH04501061A (ja) 1992-02-27
JP3095169B2 (ja) 2000-10-03
AU4410489A (en) 1990-05-14
ATE130764T1 (de) 1995-12-15
DE68924983T2 (de) 1996-06-20
AU634181B2 (en) 1993-02-18
DE68924983D1 (de) 1996-01-11
WO1990004415A1 (en) 1990-05-03
IL92009A0 (en) 1990-07-12
US6042827A (en) 2000-03-28
EP0440689A4 (en) 1991-11-27

Similar Documents

Publication Publication Date Title
Kusama et al. Characterization of syngeneic antiidiotypic monoclonal antibodies to murine anti-human high molecular weight melanoma-associated antigen monoclonal antibodies.
US20070036798A1 (en) Method and composition for reconforming multi-epitopic antigens to initiate an immune response
IE920786A1 (en) Anti-idiotype antibodies to human melonoma-associated¹proteoglycan antigen
JPH11500607A (ja) マウスモノクローナル抗イディオタイプ抗体３ｈ１
HU194497B (en) Process for producing compositions for provocating immunreply against tumors and virus
Herlyn et al. Immunomodulatory Activity of Monoclonal Anti-Idiotypic Antibody to Anti-Colorectal Carcinoma Antibody CO 17-1A in Animals and Patients
Durrant et al. An idiotypic replica of carcinoembryonic antigen inducing cellular and humoral responses directed against human colorectal tumours
AU634181B2 (en) Anti-idiotypic antibody induction of antitumor response
Ho et al. In vitro immunization of human lymphocytes. I. Production of human monoclonal antibodies against bombesin and tetanus toxoid.
SCHLEBUSCH et al. A monoclonal antiidiotypic antibody ACA 125 mimicking the tumor-associated antigen CA 125 for immunotherapy of ovarian cancer
Chatterjee et al. Anti-idiotype monoclonal antibodies as vaccines for human cancer
Monestier et al. Syngeneic anti-idiotype monoclonal antibodies to murine anticarcinoembryonic antigen monoclonal antibodies
JPH08510460A (ja) モノクローナル抗イディオタイプ抗ｃａ１２５抗体およびこれらを含有する医薬組成物
Kahn et al. Monoclonal antiidiotypic antibodies related to the p97 human melanoma antigen
Lee et al. Idiotypic interactions in immune responses to tumor-associated antigens
Maruyama et al. Immunization procedures for anti-idiotypic antibody induction in mice and rats
Herlyn et al. ANTI-IDIOTYPIC ANTIBODIES THAT MIMIC THE COLORECTAL CANCER ANTIGEN CO17-1A/GAT33: TWELVE
IE69384B1 (en) Novel antiidiotypic monoclonal antibodies
CA1341566C (en) Immune response to tumors induced by anti-idiotype antibodies
Iribe et al. Induction of an anti-human type II collagen response by monoclonal anti-idiotypic antibody.
Elagib et al. Characterization and VH sequences of human monoclonal anti-F (ab′) 2 autoantibodies from normals and Sjögren's syndrome patients
US20060159688A1 (en) Method for diagnosing efficacy of xenotypic antibody therapy
Ma et al. Characterization and evaluation of a novel anti-MUC-1 monoclonal antibody: induction of the idiotypic network in experimental mice
Courtenay-Luck et al. Diversity of the human immune response to clinically used murine monoclonal antibodies
Muralidhar et al. Monoclonal antibodies specific against tumors and viral infections

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired
ERR Corrigendum

Free format text: ADD DIVISION 130486